Altimmune's total assets for Q4 2025 were $279.93M, an increase of 28.15% from the previous quarter. ALT total liabilities were $55.04M for the fiscal quarter, a 67.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.